UroGen Pharma (URGN) Tops Q2 EPS by 8c, beats revenue, reiterates guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. BIRK

Go back to UroGen Pharma (URGN) Tops Q2 EPS by 8c, beats revenue, reiterates guidance
(NASDAQ: URGN) Delayed: 48.12 -0.88 (1.8%)
Previous Close $49.00    52 Week High $ 
Open $49.60    52 Week Low $ 
Day High $49.60    P/E N/A 
Day Low $47.67    EPS $ 
Volume 859,984